Equillium, Inc. (EQ)
NASDAQ: EQ · IEX Real-Time Price · USD
0.818
+0.018 (2.21%)
At close: Jul 26, 2024, 4:00 PM
0.820
+0.002 (0.23%)
After-hours: Jul 26, 2024, 6:28 PM EDT

Equillium Revenue

Equillium had revenue of $10.69M in the quarter ending March 31, 2024, with 20.39% growth. This brings the company's revenue in the last twelve months to $37.89M, up 53.80% year-over-year. In the year 2023, Equillium had annual revenue of $36.08M with 128.97% growth.

Revenue (ttm)
$37.89M
Revenue Growth
+53.80%
P/S Ratio
0.76
Revenue / Employee
$861,227
Employees
44
Market Cap
28.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 713.56M
Accelerate Diagnostics 12.17M
Bolt Biotherapeutics 11.32M
Palatin Technologies 5.90M
Femasys 1.05M
Orgenesis 529.00K
Revenue Rankings